Results 171 to 180 of about 204,272 (330)

Evaluation of Angiotensin Converting Enzyme (ACE) in the Pharmacokinetics and Pharmacodynamics of ACE Inhibitors

open access: bronze, 1986
C. I. Johnston   +4 more
openalex   +1 more source

Prognostic utility of advanced lung cancer inflammation index in heart failure with preserved ejection fraction

open access: yesESC Heart Failure, EarlyView.
The advanced lung cancer inflammation index (ALI) is an integrated marker of inflammation and nutritional status, calculated by body mass index × serum albumin / neutrophil‐to‐lymphocyte ratio. Low ALI levels were significantly associated with poor prognosis in elderly multimorbid HFpEF patients.
Daisuke Sakamoto   +19 more
wiley   +1 more source

Improvements in medical therapy and prognosis for patients with HFrEF following the 2021 ESC HF guidelines

open access: yesESC Heart Failure, EarlyView.
Abstract Aims The guideline‐directed medical therapy (GDMT) sequencing strategy for patients with heart failure (HF) and reduced ejection fraction (HFrEF) underwent a paradigm shift with the 2021 ESC HF guidelines, from stepwise escalation to rapid simultaneous initiation of quadruple therapy.
Kristian Berge   +12 more
wiley   +1 more source

Discovery and biosynthesis of karnamicins as angiotensin converting enzyme inhibitors. [PDF]

open access: yesNat Commun, 2023
Yu Z   +9 more
europepmc   +1 more source

Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers

open access: yesCancer, 2016
Z. Morris   +12 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy